Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5176031 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL4396035 | 0.94 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL10938071 | 0.94 | TSHR (0.42) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL2400345 | 0.94 | TSHR (0.42) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL4863 | 0.94 | — | — | |
| SCHEMBL4390925 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL21435871 | 0.92 | — | — | |
| SCHEMBL4393806 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL5175314 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4THRBEPHX2 | |
| SCHEMBL3581454 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP3A4THRBEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132675-A1 | POLYMER HAVING METAL-OXYGEN-METAL BOND AS PRIMARY CHAIN, COMPOSITION THEREOF, SOLID MATERIAL AND PRODUCTION METHOD THEREOF, AND ELECTRONIC COMPONENT AND FIBER | TORAY INDUSTRIES, INC. (JP) | 2024-04-25 | — | — | US | disclosed |
| US-9364408-B2 | Hair dye agent comprising aminopyrimidine derivatives | HENKEL AG & CO. KGAA (DE) | 2016-06-14 | — | — | US | disclosed |
| US-9364407-B2 | Hair dye agent comprising aminopyrimidine derivatives | HENKEL AG & CO. KGAA (DE) | 2016-06-14 | — | — | US | disclosed |
| US-20150209258-A1 | HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2015-07-30 | — | — | US | disclosed |
| US-20150209257-A1 | HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2015-07-30 | — | — | US | disclosed |
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-7605263-B2 | Fluorescent naphthalene-1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus | INFINEON TECHNOLOGIES AG (DE) | 2009-10-20 | — | — | US | disclosed |
| US-7405030-B2 | Imide compound and optical recording media made by using the same | MITSUI CHEMICALS, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| EP-1930339-A2 | Imide compound | MITSUI CHEMICALS, INC. (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20070259151-A1 | Imide compound and optical recording media made by using the same | MITSUI CHEMICALS, INC. (JP) | 2007-11-08 | — | — | US | disclosed |
| EP-0501167-B1 | Liquid dye preparations | BASF AG (DE) | 1995-07-05 | — | — | EP | disclosed |
| EP-0656929-A1 | USE OF COMPOUNDS WHICH ABSORB AND/OR FLUORESCE IN THE I/R RANGE AS MARKERS FOR LIQUIDS. | BASF AG (DE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0645259-A1 | Thermal transfer of infrared dye-stuffs | BASF Aktiengesellschaft (DE) | 1995-03-29 | — | — | EP | disclosed |
| EP-0628607-A2 | Naphthalocyanine | BASF Aktiengesellschaft (DE) | 1994-12-14 | — | — | EP | disclosed |
| EP-0619346-A1 | Lacquered tris-or tetracationic polymethin dyes | BASF Aktiengesellschaft (DE) | 1994-10-12 | — | — | EP | disclosed |
| WO-1994002570-A1 | USE OF COMPOUNDS WHICH ABSORB AND/OR FLUORESCE IN THE I/R RANGE AS MARKERS FOR LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-03 | — | — | WO | disclosed |
| US-5282894-A | Use of a liquid containing IR dyes as printing ink | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-01 | — | — | US | disclosed |
| EP-0553614-A1 | Use of infrared dyes containing liquid as a printing ink | BASF Aktiengesellschaft (DE) | 1993-08-04 | — | — | EP | disclosed |
| US-5205838-A | LIQUID DYE PREPARATIONS: BIS PHENYL-AZO-RESORCINOL IN SOLVENT FOR COLORED RIBBON OR BALL PEN INK | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-27 | — | — | US | disclosed |
| EP-0501167-A1 | Liquid dye preparations | BASF Aktiengesellschaft (DE) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150209257-A1 | HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES | H1-4, H1-2, QDPR | ALDH1A1 72/4885TSHR 3128/4885CYP3A4 2674/4885 |
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | ALDH1A1 4231/4885TSHR 3610/4885CYP3A4 2777/4885 |
| US-20150209258-A1 | HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES | KRT18, DPYD, DHFR | ALDH1A1 204/4885TSHR 4364/4885CYP3A4 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.